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Abstract
Background: NSC-741909 is a novel anticancer agent that can effectively suppress the growth of several cell lines 
derived from lung, colon, breast, ovarian, and kidney cancers. We recently showed that NSC-741909-induced antitumor 
activity is associated with sustained Jun N-terminal kinase (JNK) activation, resulting from suppression of JNK 
dephosphorylation associated with decreased protein levels of MAPK phosphatase-1. However, the mechanisms of 
NSC-741909-induced antitumor activity remain unclear. Because JNK is frequently activated by oxidative stress in cells, 
we hypothesized that reactive oxygen species (ROS) may be involved in the suppression of JNK dephosphorylation 
and the cytotoxicity of NSC-741909.
Methods: The generation of ROS was measured by using the cell-permeable nonfluorescent compound H2DCF-DA 
and flow cytometry analysis. Cell viability was determined by sulforhodamine B assay. Western blot analysis, 
immunofluorescent staining and flow cytometry assays were used to determine apoptosis and molecular changes 
induced by NSC-741909.
Results: Treatment with NSC-741909 induced robust ROS generation and marked MAPK phosphatase-1 and -7 
clustering in NSC-741909-sensitive, but not resistant cell lines, in a dose- and time-dependent manner. The generation 
of ROS was detectable as early as 30 min and ROS levels were as high as 6- to 8-fold above basal levels after treatment. 
Moreover, the NSC-741909-induced ROS generation could be blocked by pretreatment with antioxidants, such as 
nordihydroguaiaretic acid, aesculetin, baicalein, and caffeic acid, which in turn, inhibited the NSC-741909-induced JNK 
activation and apoptosis.
Conclusion: Our results demonstrate that the increased ROS production was associated with NSC-741909-induced 
antitumor activity and that ROS generation and subsequent JNK activation is one of the primary mechanisms of NSC-
741909-mediated antitumor cell activity.
Background
We recently identified a small molecule (oncrasin-1)
through cell-based synthetic lethality screening that can
effectively kill several lung cancer cell lines harboring
mutant K-Ras genes [1]. Subsequent analyses of oncrasin-
1 analogues led us to identify several active compounds
with similar chemical structures. NSC-741909 is one of
the oncrasin-1 analogues that was highly active against
several cell lines derived from lung, colon, breast, ovar-
ian, and kidney cancers when tested in NCI-60 cancer
cell lines by the Developmental Therapeutics Program at
the National Cancer Institute. Using a reverse-phase pro-
tein microarray assay, we determined molecular changes
in 77 protein biomarkers in an oncrasin-sensitive lung
cancer cell line after treatment with NSC-741909 [2].
These results showed that treatment with NSC-741909
induced persistent activation of mitogen-activated pro-
tein kinases (MAPKs), including p38 MAPK, Jun N-ter-
minal kinase (JNK), and extracellular signal-regulated
kinase (ERK), and that persistent JNK activation is associ-
ated with apoptosis induction by this compound [2]. Fur-
ther studies revealed that treatment with NSC-741909
suppressed MAPK phosphatase-1 expression and JNK
dephosphorylation, in a dose-dependent manner [2].
Those results suggest that inhibition of JNK dephospho-
rylation is one of the molecular mechanisms critical for
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the NSC-741909-induced sustained activation of JNK
and cell death.
JNKs are activated by dual phosphorylation on the Thr-
Pro-Tyr motif in the activation loop through mitogen-
activated protein kinase kinase 4 (MKK4) and 7 (MKK7)
and inactivated by dephosphorylation through a group of
MAP kinase phosphatases [3]. MAP kinase phosphatases
(MKPs) are a group of dual-specificity phosphatases that
inactivate MAPKs by dephosphorylating their threonine
and tyrosine residues. At least 16 mammalian dual-speci-
ficity phosphatases that can dephosphorylate MAPKs
have been identified [4]. Their tissue-specific transcrip-
tional regulation, expression patterns, substrate specifici-
ties, and subcellular localization play critical roles in
controlling MAPK activity and signal transduction in
e a c h  c e l l  t ype  [ 4 ] .  A c c u m u l a t i n g  evi d e n c e  h a s  d e m o n -
strated that, like other protein tyrosine phosphatases, the
conserved catalytic cysteine residue in the active motif of
MKPs is highly susceptible to reversible oxidation by
local reactive oxygen species (ROS) such as hydrogen
peroxide (H2O2) [5,6], which leads to inactivation of
MKPs and activation of MAPKs [7-9]. ROS-mediated
i n h i b i t i o n  o f  M K P s  i s  c r i t i c a l  f o r  T N F α - i n d u c e d  s u s -
tained activation of JNK and subsequent apoptosis [7].
Interestingly, ROS were recently identified as common
mediators of antibiotic-induced cell death in bacteria
[10]. Moreover, many anticancer drugs act as prooxi-
dants, which may trigger the generation of free radicals,
such as ROS or reactive nitrogen species [11,12], and pro-
mote apoptosis. In fact, ROS-induced oxidative stress
and cell death play important roles in the efficacy of many
antineoplastic agents [13,14].
To investigate whether oxidative stress is involved in
the cytotoxicity of oncrasin compounds, we examined the
production of ROS and its effects on JNK activation and
cell death after treatment of oncrasin-sensitive and -resis-
tant cells with NSC-741909. We found that ROS forma-
tion is an important component of NSC-741909-induced
apoptosis. Furthermore, the NSC-741909-induced gener-
ation of ROS, cytotoxicity, and JNK activation, could be
dramatically attenuated by some antioxidants, such as
nordihydroguaiaretic acid, aesculetin, baicalein, and caf-
feic acid.
Methods
Cell lines and cell culture conditions
The human non-small cell lung carcinoma cell lines
H460, H157, H322, and H1299 were grown in Dulbecco's
modified Eagle's medium supplemented with 10% fetal
bovine serum and 100 mg/mL penicillin-streptomycin
(all from Life Technologies, Gaithersburg, MD, USA).
Normal bronchial epithelial cells (HBEC) were kindly
provided by Dr. John Minna (Southwest Medical School,
Dallas, TX) and were cultured in serum-free keratinocyte
medium (Invitrogen Corporation, Carlsbad, CA). Cells
were cultured at 37°C in a humidified incubator contain-
ing 5% CO2.
Chemicals and antibodies
NSC-741909 (the structure was shown in additional file
1) was synthesized by Zhejiang Yuancheng MST Inc.
(Hangzhou, China). This compound was 98.5% pure, as
determined by high-performance liquid chromatogra-
phy--mass spectrometry (LC/MS) analysis. The chemical
structure was confirmed by nuclear magnetic resonance.
N-acetylcysteine (NAC), rotenone, Nω-nitro-L-arginine
methyl ester (L-NAME), diallyl sulfide (DSE), naproxen,
oxypurinol, nordihydroguaiaretic acid (NDGA), baica-
lein, caffeic acid, MK886, and zileuton were purchased
from Calbiochem (San Diego, CA, USA). Antibodies to
the following proteins were used for Western blot analy-
sis: JNK, phospho-JNK, phospho-c-Jun (Cell Signaling
Technology, Danvers, MA, USA), poly-(ADP-ribose)
polymerase (BD Biosciences Pharmingen, San Diego, CA,
USA), MKP1 (Santa Crutz, CA, USA), MKP7 (Sigma-
Aldrich, St. Louis, MO, USA), caspase-8 (Alexis Bio-
chemicals, Farmingdale, NY, USA), β-actin, and hemag-
glutinin (HA) (Sigma-Aldrich, St. Louis, MO, USA). 2',7'-
Dichlorofluorescein diacetate (H2DCF-DA) was pur-
chased from Invitrogen Molecular Probes (Carlsbad, CA,
USA).
ROS analysis
The cell-permeable nonfluorescent compound H2DCF-
DA was used for measuring intracellular ROS. Inside
cells, H2DCF-DA is de-esterified to 2', 7'-dichlorofluores-
cein (H2DCF), which is further oxidized by ROS to fluo-
rescent dichlorofluorescein (DCF) that remains inside the
c e l l s  a n d  c a n  b e  q u a n t i f i e d  b y  f l o w  c y t o m e t r y ,  a s
described in the manufacturer's instructions. H2DCF-DA
was dissolved in dimethylsulfoxide and diluted with
phosphate-buffered saline (PBS) to a final concentration
of 5 μmol/L. Cells were seeded at a density of 2.5 × 105
cells/well in six-well plates and allowed to grow over-
night. The cells were treated either with different concen-
trations of NSC-741909 for 6 h or with 1 μM NSC-
741909 for different time periods (0.5, 2, 4, 6 h). Subse-
quently, 5 μmol/L H2DCF-DA was added, and cells were
incubated for 40 min at 37°C; cells were then returned to
a prewarmed growth medium and incubated for 10 min
at 37°C. Cells were harvested with trypsin and washed
once with PBS, and the fluorescence intensity was deter-
mined using flow cytometry, with excitation and emis-
sion settings of 488 nm and 530 nm, respectively. The
mean fluorescence peak was analyzed from the gated cell
population of 10,000 cells. For the NSC-741909-antioxi-
dant combination test, the antioxidants were added 30
min before NSC-741909. All experiments were per-Wei et al. Journal of Translational Medicine 2010, 8:37
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formed three times. The flow cytometry assays were per-
formed at the Flow Cytometry and Cellular Imaging
Facility at The University of Texas M. D. Anderson Can-
cer Center.
Cell viability assay
Cells were seeded at a density of 1 × 104 cells/well in 96-
well plates. After overnight incubation, the cells were
treated with NSC-741909 (0.03 - 10 μM), either alone or
in combination with different antioxidant compounds for
24 h. The antioxidants were added 30 min before NSC-
741909 was added, and the inhibitory effects of NSC-
741909, alone or in combination with the antioxidants,
on cell growth were determined using the sulforhod-
amine B (SRB) assay, as described previously [15]. We
determined the relative cell viability by normalizing the
cells to the dimethylsulfoxide-treated control cells, which
was set at 100%. Each experiment was performed in qua-
druplicate and repeated for a total of at least three times.
Apoptosis analysis
The flow cytometry assay was performed as described
previously [16]. In brief, cells were seeded at a density of
2.5 × 105 cells/well in six-well plates and allowed to grow
overnight. The cells were treated with NSC-741909 (1
μM) alone or in combination with different antioxidants
for 24 h. The antioxidants were added to the cells 30 min
before NSC-741909 was added. After treatment, the cells
were harvested with trypsin, washed once with PBS, and
fixed by incubation with 70% ethanol overnight at 4°C.
Before flow cytometry analysis, cells were stained with
propidium iodide (PI; 1 ml PI, 10 μl RNase, 9 ml PBS;
final PI concentration of 50 μg/ml) for 30 min. A flow
cytometry assay was used to measure the sub-G0/G1 cel-
lular DNA content using Cell Quest software (Becton-
Dickinson (Franklin Lakes, NJ, USA). All experiments
were performed three times. The flow cytometry assays
were performed in the Flow Cytometry and Cellular
Imaging Facility at M. D. Anderson Cancer Center.
Western blot analysis
Cells were washed with cold PBS and subjected to lysis in
Laemmli's lysis buffer. The protein concentration was
determined using the Bradford method. Equal amounts
of lysate (40 μg) were separated by 10% sodium dodecyl
sulfate-polyacrylamide gel electrophoresis and then
transferred to Hybond-enhanced chemiluminescence
membranes (GE Healthcare Life Sciences, Piscataway, NJ,
USA). Membranes were then blocked with PBS contain-
ing 5% low-fat milk and 0.05% Tween (PBST) for 1 h and
then incubated with primary antibodies overnight at 4°C.
After being washed three times with PBST, membranes
were incubated with peroxidase-conjugated secondary
antibodies for 1 h at room temperature. The membranes
were washed with PBST again and developed with a
chemiluminescence detection kit (ECL kit; GE Health-
care Life Sciences). β-Actin was used as a loading control.
Immunofluorescent staining
Cells were seeded at a density of 1 × 105 cells per well in
6-well plates containing a 1% gelatin-treated cover slide.
Cells were allowed to grow overnight. Cells were treated
with 1 μM NSC-741909 for different time periods as indi-
cated. After the treatment, cells were washed with PBS
twice, then fixed with 2% paraformaldehyde for 20 min,
permeablized with 0.1% Triton-100 for 20 min, and
blocked with 5% normal goat serum for 1 h. The slides
were incubated with primary antibodies followed by
FITC or Rhodamine-linked secondary antibodies. After
washed with PBS thrice, the slides were taken out and
mounted with Prolong Gold antifade reagent (Molecular
Probes, Carsbad, CA, USA). The slides were read under
Olympus fluorescence microscope (Olympus, Melville,
NY, USA).
Statistical analysis
Statistical differences between treatment groups were
assessed by analysis of variance (ANOVA) using StatSoft
software (Tulsa, OK, USA). P values of < 0.05 were
regarded as significant.
Results
NSC-741909 induced MKP1 and MKP7 clustering and 
generation of reactive oxygen species in oncrasin-sensitive 
cells
Our recent study showed that NSC-741909 induced sus-
tained JNK activation associated with decreased protein
levels of MKP1, one of MAP kinase phosphatases that
inactivate JNK and p38 MAP kinases [2]. Interestingly,
NSC-741909 induced an increase of MKP1 mRNA
expression in both time- and dose-dependent manner.
The peak occurred at 1 h post-treatment, which had 5-10
fold increase when compared with DMSO treated control
[2], suggesting that NSC-741909 may suppress MKP1
expression at the post-transcriptional level and that
increased MKP1 mRNA expression might reflect a nega-
tive feedback to the decrease of its protein levels. Because
MKPs are highly susceptible to oxidative stress, which
can induce aggregations of MKPs, we further tested
MKP1 and MKP7 statuses by immunohistochemical
staining after treatment with NSC-741909. The result
showed that treatment of H460 cells with 1 μM of NSC-
741909 induced cluster formation of MKP1 and MKP7 at
all time points examined (2 - 8 h after the treatment) (Fig.
1A, B), suggesting that oxidative stress might play roles in
alteration of MKP1 and MKP7, both are responsible for
inactivating JNK through dephosphorylation.
To determine whether treatment with NSC-741909
would generate oxidative stress in sensitive cells, we
treated two sensitive lung cancer cell lines, H460 andWei et al. Journal of Translational Medicine 2010, 8:37
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H157, with 1 μM NSC-741909. Cells were stained with
H2DCF-DA, and were examined for the production of
ROS by measuring the cell population with positive DCF-
derived fluorescence at various time points after the
NSC-741909 treatment. Cells treated with solvent alone
(dimethylsulfoxide) and stained with H2DCF-DA were
used as controls. We found that treatment with NSC-
741909 stimulated ROS generation in a time-dependent
manner in both cell lines, in contrast to the control cells
(Fig. 1C). An increase in the amount of ROS generated
occurred as early as 30 min to 1 h after treatment and was
as high as 6- to 8-fold above baseline levels after 6 h. Sim-
ilar results were obtained with cells that were treated with
the lead compound, oncrasin-1 (data not shown). We
then evaluated the generation of ROS as a function of
NSC-741909 concentration 6 h after treatment with
NSC-741909. The result showed that the generation of
ROS by NSC-741909 was dose-dependent and detectable
at a dose of 50 nM in both cell lines (Fig. 1D).
Association between NSC-741909-induced generation of 
reactive oxygen species and suppression of cell growth
To investigate whether NSC-741909-mediated ROS gen-
eration was correlated with NSC-741909-mediated cell
growth suppression, we measured cell viability and ROS
generation after NSC-741909 treatment in two sensitive
(H460 and H157) and two resistant (H322, H1299) lung
cancer cell lines. Normal bronchial epithelial cells
(HBEC), which is resistant to NSC-741909, were also
included in the studies. The cells were treated with 0.03 -
10 μM NSC-741909 for 24 h and then cell viability was
determined by using the SRB assay. To test for the genera-
tion of ROS, the cells were treated with 1 μM NSC-
741909 for 6 h and then stained with H2DCF-DA, as
described earlier. The results showed that treatment with
NSC-741909 markedly suppressed cell growth in a dose-
dependent manner in both the H460 and H157 cells, with
a 50% growth-inhibitory concentration of 0.2 μM and 0.1
μM respectively. In comparison, H322, H1299 and HBEC
were resistant to NSC-741909, with a 50% growth-inhibi-
tory concentration of more than 10 μM, the highest con-
centration tested (Fig. 2A). The NSC-741909-induced
ROS production paralleled the results of the cell viability
experiment; ROS generation increased markedly after
exposure of H460 and H157 cells to NSC-741909 (1 μM)
for 6 h as compared with the solvent-treated controls
(data not shown). In contrast, we did not detect any ROS
in H322 and H1299 cells 6 h after NSC-741909 treatment,
even at a concentration of 10 μM, although a mild ROS
increase (<0.6 fold) was observed in HBEC under the
same treatment (Fig. 2B). These data show that the
increased ROS production coincides with the suppres-
sion of cell growth after NSC-741909 treatment.
Antioxidant blocks NSC-741909-induced ROS production 
and suppression of cell growth
ROS, such as hydrogen peroxide (H2O2), superoxide (O2-
), and hydroxyl radical (OH·), are generated in cells by
Figure 1 NSC-741909-induced MKP1 and MKP7 clustering, and ROS production in sensitive cell lines. (A, B), Clustering of MKP1 (A) and MKP7 
(B). H460 cells were treated with 1 μM NSC-741909 for the indicated time periods. MKP1 and MKP7 were detected by immunohistochemical staining. 
(C) and (D) ROS induction in H460 and H157 cells after treatment with 1 μM NSC-741909 for the indicated time periods (C), or with different concen-
trations of NSC-741909 (0.01 - 1 μM) for 6 h (D). Cells were stained with 2', 7'-dichlorofluorescein diacetate and the fluorescent cell population was 
counted by flow cytometry. Cells treated with solvent alone (dimethylsulfoxide, DMSO) were used as controls, and their mean fluorescence intensity 
was set at 1. Each data point represents the mean ± SD of three independent experiments. *p < 0.05, **p < 0.01, compared with cells treated with 
DMSO alone.Wei et al. Journal of Translational Medicine 2010, 8:37
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several pathways. Most cellular O2- is generated during
electron transport through the mitochondrial respiratory
chain reactions mediated by the coenzyme Q and ubiqui-
none complexes. O2- is also generated by NADPH cyto-
chrome P450 reductase, hypoxanthine/xanthine oxidase,
NADPH oxidase, lipoxygenase (LOX), and cyclooxyge-
nase [17]. Superoxide dismutase converts O2- into H2O2,
and H2O2 is mostly converted into H2O by glutathione
(GSH) peroxidase and catalase. H2O2 produces the highly
reactive OH· by the Fenton/Haber-Weiss reaction in the
presence of iron [17]. To further examine the role of the
ROS generated by treatment of cells with NSC-741909,
we evaluated whether the NSC-741909-generated ROS
could be inhibited by various antioxidant agents. For this
purpose, we treated cells with 10 mM NAC (an antioxi-
dant [18]), 1 μM rotenone (a mitochondrial electron
transport chain inhibitor [19]), 300 μM L-NAME (a
nitric-oxide synthase inhibitor [20]), 10 μM DSE (an
inhibitor of cytochrome P450 2E1 [21]), 300 μM
naproxen (a cyclooxygenase inhibitor [22]), 1 mM oxy-
purinol (a hypoxanthine/xanthine oxidase inhibitor [23]),
or 20 μM NDGA (an antioxidant and LOX inhibitor [24])
30 min prior to the addition of NSC-741909. Generation
of ROS was then measured 6 h after treatment with NSC-
741909. The results showed that the NSC-741909-
induced generation of ROS in H460 cells was substan-
tially diminished by pretreatment with NDGA, but not by
pretreatment with any of the other antioxidant agents
(Fig. 3A). The cell viability analysis also revealed that only
NDGA blocked the NSC-741909-induced growth sup-
pression, with a 50% growth-inhibitory concentration of
more than 10-fold shift, whereas NAC, rotenone, L-
NAME, DSE, naproxen, and oxypurinol had no obvious
effect on cell growth (Fig. 3B). These results indicate that
NSC-741909 may induce oxidative stress through a spe-
cific pathway that is affected by NDGA or that NDGA is
potent antioxidant that can effectively block NSC-741909
induced oxidative stress.
NDGA inhibits NSC-741909-induced apoptosis
Our previous studies have demonstrated that the reduc-
tion in cell viability caused by oncrasin compounds is
mainly caused by apoptosis induction [2]. To further eval-
uate whether NDGA blocks NSC-741909-mediated cell
killing, we tested the effects of NDGA and NAC on apop-
tosis induction by NSC-741909. H460 cells were treated
with 1 μM NSC-741909 for 24 h, with or without the
prior addition of NDGA or NAC, and the percentage of
apoptotic cells was determined by flow cytometry analy-
sis.
The results showed that treatment with NSC-741909
alone led to a dramatic increase in the number of apop-
totic cells (those in the sub-G1 phase) as compared with
cells treated with solvent (Fig. 4A). Treatment of cells
with either NAC (10 mM) or NDGA (20 μM) alone did
not affect the cell growth cycle or induce apoptosis. Pre-
treatment of cells with NDGA (20 μM) markedly
Figure 2 Antitumor cell activity of NSC-741909 is associated with ROS generation. (A) Two sensitive (H460 and H157 cells) and two resistant 
lung cancer cell lines (H322 and H1299) were treated with different concentrations of NSC-741909 (0.03 - 10 μM). Cell viability was determined 24 h 
after treatment. Cells treated with solvent (dimethylsulfoxide) alone were used as controls, and their viability was set to 100%. Each data point repre-
sents the mean ± SD of three independent experiments. (B) The five cell lines were treated with 1 μM NSC-741909 for 6 h and then stained with 2', 7'-
dichlorofluorescein diacetate. Fluorescence intensity in cell samples was determined by flow cytometry analysis. Shown here are representative FACS 
graphs, which show the shift in the fluorescent cell population after NSC-741909 treatment (dark lines) when compared with control cells (light lines).Wei et al. Journal of Translational Medicine 2010, 8:37
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decreased the percentage of apoptotic cells compared
with NSC-741909 treatment alone (1.7% vs. 32.7%,
respectively). In contrast, pretreatment with NAC had no
effect on the NSC-741909-induced apoptosis (Fig. 4A and
4B).
The effect of NDGA on NSC-741909-induced apopto-
sis was further verified by Western blot analysis. Pretreat-
ment of cells with NDGA (20 μM) markedly blocked the
NSC-741909-induced activation of caspase-8 and cleav-
age of poly-(ADP-ribose) polymerase (Fig. 4C). However,
pretreatment with NAC did not have a similar effect.
Together, these results indicate that NDGA inhibits NSC-
741909-mediated apoptosis.
Effects of other antioxidants on NSC-741909-induced 
generation of ROS
NDGA is known as an antioxidant and a nonselective
LOX inhibitor [25]. In mammalian cells, there are three
subtypes of LOX, 5-, 12-, and 15-LOX [26,27]. To investi-
gate whether other LOX inhibitors have effects similar to
those of NDGA on NSC-741909-mediated cell death, we
evaluated the effects on NSC-741909's antitumor cell
activity of several LOX inhibitors, including aesculetin (a
nonselective LOX inhibitor), MK886 (an inhibitor of the
5-LOX-activating protein), zileuton (a 5-LOX inhibitor),
baicalein (a 12/15-LOX inhibitor), and caffeic acid (a 5/
15-LOX inhibitor). The results showed that antioxidants
aesculetin (20 μM), baicalein (10 μM), and caffeic acid (10
μM) significantly blocked the NSC-741909-induced ROS
generation (Fig. 5A, P < 0.01) and apoptosis (Fig. 5B, P <
0.01), whereas non-antioxidants MK886 (10 μM) and
zileuton (20 μM) had no such inhibitory effect. The cell
viability analysis further revealed that antioxidants aescu-
letin (20 μM), baicalein (10 μM), and caffeic acid (10 μM)
also significantly reversed the NSC-741909-induced
growth suppression at doses of 0.03 - 10 μM, each with a
50% growth-inhibitory concentration of more than 10-
fold shift, whereas MK886 (10 μM) and zileuton (20 μM)
had no obvious effect on the growth suppression at those
concentrations (Fig. 5C). These data suggest that NDGA,
aesculetin, baicalein and caffeic acid may block NSC-
741909-induced ROS independent of Lox activities. In
fact, siRNA of 5-, 12-, and 15-Lox had no effects on NSC-
741909-induced ROS generation and cell killing (Addi-
tional file 2), further indicating that those antioxidants
mediated antagonist effect was independent of Lox activ-
ities.
Suppression of NSC-741909-induced JNK/c-Jun activation 
by antioxidants
We recently found that sustained activation of JNK con-
tributes to the apoptosis induced by NSC-741909 [2].
Therefore, we tested whether the antioxidants that can
block the NSC-741909-induced generation of ROS and
apoptosis can also inhibit the NSC-741909-induced acti-
vation of JNK and its downstream target c-Jun. We found
that treatment of H460 cells with either NDGA (20 μM)
or caffeic acid (10 μM) alone had no effect on the expres-
sion of either JNK or c-Jun, but pretreatment of cells with
NDGA (20 μM) or caffeic acid (10 μM) markedly blocked
the NSC-741909-induced phosphorylation of JNK and c-
Jun, without any obvious effect on the basal JNK level
(Fig. 6A). These data showed that either NDGA (20 μM)
or caffeic acid (10 μM) was sufficient to block the NSC-
741909-mediated activation of JNK. In comparison, zile-
uton, which had no effect on NSC-741909-induced ROS
generation and apoptosis induction, also had no effect on
the phosphorylation of JNK and c-Jun induced by NSC-
Figure 3 Effects of antioxidants on ROS production and cell 
growth suppression induced by NSC-741909. Cells were treated 
with 1 μM NSC-741909 for 6 h (for ROS generation) or 24 h (for cell vi-
ability) in the presence or absence of different inhibitors. (A) After treat-
ment, cells were stained with 2', 7'-dichlorofluorescein diacetate, and 
the fluorescent cell population was counted by flow cytometry and 
the relative ROS production was calculated. **p < 0.01, compared with 
cells treated with NSC-741909 alone. (B) Cell viability was determined 
using the sulforhodamine B assay. Cells treated with solvent (dimeth-
ylsulfoxide) alone were used as controls, with their viability set at 100%. 
Each data point represents the mean ± SD of three independent ex-
periments. NAC, N-acetylcysteine; L-NAME, Nω-nitro-L-arginine meth-
yl ester, a nitric-oxide synthase inhibitor; DSE, diallyl sulfide, an inhibitor 
of cytochrome P450 2E1; naproxen, cyclooxygenase inhibitor; oxy-
purinol, hypoxanthine/xanthine oxidase inhibitor; and NDGA, nordihy-
droguaiaretic acid, a lipoxygenase inhibitor.Wei et al. Journal of Translational Medicine 2010, 8:37
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741909 (Figures 6A and 6B). These data further indicate
that NSC-741909-induced generation of ROS may con-
tribute to the sustained activation of JNK in oncrasin-
sensitive cells, which in turn, is critical for NSC-741909-
mediated apoptosis.
Discussion
Our results demonstrate that NSC-741909 can effectively
induce ROS generation in oncrasin-sensitive, but not in
the resistant human lung cancer cells. Blocking NSC-
741909-induced ROS generation with some antioxidants,
such as NDGA, aesculetin, baicalein, and caffeic acid,
effectively blocked NSC-741909-induced cell death. Fur-
thermore, these antioxidants also blocked JNK activation,
demonstrating that ROS generation is one of the primary
mechanisms by which NSC-741909 induces the sustained
activation of JNK and apoptosis.
ROS are constantly generated and eliminated inside a
cell. The balance of ROS can be dramatically affected by
many environmental stimuli, including cytokines, growth
factors, ultraviolet radiation, radiotherapy, and chemo-
therapeutic agents. ROS generation and subsequent oxi-
dative damage to the cell membrane is one of the major
mechanisms of radiotherapy-mediated apoptotic cell
death [28]. Similarly, many chemotherapeutic agents,
including cisplatin [29], paclitaxel [30], doxorubicin
[31,32], and the histone deacetylase inhibitor suberoyla-
nilide hydroxamic acid, induce ROS generation in target
cells [33]. Moreover, scavenging of ROS with antioxidants
causes cells to resist apoptosis induced by gamma-irradi-
ation and various chemotherapeutic agents [34].
Interestingly, ROS production is often elevated in onco-
gene-transformed cells. For example, transformation of
cells with oncogenic Ras leads to increased production of
Figure 4 NDGA inhibits NSC-741909-induced apoptosis and caspase-8 and poly-(ADP-ribose) polymerase (PARP) activation. H460 cells 
were treated with 1 μM NSC-741909 in the presence or absence of 10 mM N-acetyl cysteine (NAC) or 20 μM nordihydroguaiaretic acid (NDGA). Cells 
treated with solvent (dimethylsulfoxide) or the antioxidants alone were used as controls. (A) Percentage of apoptotic cells was determined by flow 
cytometry analysis 24 h after treatment. The values shown represent the mean ± SD of three analyses. **p < 0.01, compared with cells treated with 
NSC-741909 alone. (B) Representative FACS graphs. (C) Whole-cell lysates from H460 cells treated as described above were harvested for Western blot 
analysis of caspase-8 and PARP activation.
Figure 5 Effects of other lipoxygenase (LOX) inhibitors on ROS generation and apoptosis induced by NSC-741909. Cells were treated with 1 
μM NSC-741909 for 6 h (for ROS generation) or 24 h (for analysis of apoptosis and cell viability) in the presence or absence of LOX inhibitors. (A) After 
treatment, cells were stained with 2', 7'-dichlorofluorescein diacetate, and the fluorescent cell population was counted by flow cytometry and relative 
ROS production was calculated. (B) Percentage of apoptotic cells determined by flow cytometry. **p < 0.01, compared with cells treated with NSC-
741909 alone. (C) Percentage of viable cells determined by the sulforhodamine B assay. Cells treated with solvent (dimethylsulfoxide) alone were used 
as a control, with viability set at 100%. Each data point represents the mean ± SD of three independent experiments.Wei et al. Journal of Translational Medicine 2010, 8:37
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O2-, which can be suppressed by the expression of domi-
nant-negative isoforms of Ras or Rac1 [35,36]. Similarly,
increased Akt activity sensitizes cells to ROS-mediated
apoptosis by increasing the intracellular concentration of
ROS through increased oxygen consumption and inhibi-
tion of the expression of ROS scavengers downstream of
FoxO, particularly manganese superoxide dismutase [37]
and sestrin 3 [38]. In addition, overexpression of growth
factor receptors, such as insulin growth factor receptor
[39], epidermal growth factor receptor [40], and vascular
endothelial growth factor receptor [41], leads to
increased generation of ROS. Those changes were fre-
quently found in malignant cells.
Elevated levels of ROS in oncogene-transformed or
tumor cells potentiate the oxidative stress-mediated acti-
vation of MAP kinases, particularly the JNK and p38
kinases, which sensitizes those cells to chemotherapeutic
drug- and radiation-induced cell death [42]. Thus, oxida-
tive stress associated with increased activities of onco-
genes and growth factor receptors represents a specific
vulnerability of malignant cancer cells that can be selec-
tively targeted by novel oxidative stress-inducing antican-
cer agents such as NSC-741909. It has been well
documented that MAPKs, such as JNK, are redox sensi-
tive and involved in apoptosis signaling [12,43,44]. There
are two mechanisms of JNK activation: the earlier and
transient activation occurs through the pro-inflammatory
cytokine signaling cascade, and the delayed and sustained
activation is mediated by ROS [45], which inactivate
M A P  k i n a s e  p h o s p h a t a s e s  b y  r e a c t i n g  w i t h  c a t a l y t i c
cysteine and causing their aggregation. Our results also
showed that treatment with NSC-741909 induced clus-
tering of MKP1 and MKP7 in sensitive cells, suggesting
that the ROS-mediated inactivation of MKPs is a primary
mechanism by which NSC-741909 activates JNK signal-
ing pathway and exerts its antitumor cell effect. However,
cellular levels of MKPs are likely not the critical factors
for the sensitivity to NSC-741909 in lung cancer cells,
because levels of MKPs in microarrays for lung cancer
cell lines described here and that in the NCI's 60 cell line
panel did not reveal obvious association between IC50s
and MKP expression levels (Additional file 3). This may
be explained by the fact that MKPs are down stream of
ROS in inactivating JNK. Factors that directly contribute
to ROS inductions might be more important for apopto-
sis induction by NSC-741909. Nevertheless, the underly-
ing mechanisms or the sources of NSC-741909 induced
ROS remain to be characterized.
Our results showed several antioxidants, including
NDGA, aesculetin, baicalein, and caffeic acid, can block
NSC-741909-induced ROS generation, JNK activation,
and apoptosis, whereas the ROS generation was not
affected by other antioxidants, such as NAC, rotenone, L-
NAME, DSE, naproxen, and oxypurinol. Interestingly,
NDGA, aesculetin, baicalein, and caffeic acid are all
reported to inhibit LOXs through their antioxidant activ-
ity. Nevertheless, those antioxidants mediated antagonist
effect could be LOX independent because LOX inhibitors
MK886 and zileuton, which do not have any intrinsic
antioxidant activity, were not effective in blocking the
NSC-741909-mediated ROS generation, nor did LOX
specific siRNAs block NSC-741909-induced ROS genera-
tion and cell killing (Additional file 2). In addition, NAC,
which acts as a precursor of GSH synthesis, did not atten-
uate the NSC-741909-mediated ROS generation, which
suggests that the cellular reduction and oxidation regu-
lated by intracellular GSH may not be very important for
the NSC-741909-induced ROS production and cell death
effects.
Conclusion
Taken together, our results demonstrate that NSC-
741909-induced apoptosis in human lung cancer cells is
mediated by the generation of ROS. Blocking the forma-
tion of ROS could sufficiently inhibit the effects of NSC-
741909, including JNK activation, cell growth suppres-
sion, and apoptosis. These results indicate that the oxida-
tive stress-mediated sustained activation of JNK and
subsequent induction of apoptosis is likely the primary
Figure 6 Effects of antioxidants on NSC-741909-induced JNK/c-
Jun activation. (A) H460 cells were treated with 1 μM NSC-741909 in 
the presence or absence of various lipoxygenase inhibitors for 24 h. (B) 
H460 cells were treated with 1 μM NSC-741909 in the presence or ab-
sence of 10 mM of N-acetylcysteine (NAC) for 24 h. Whole-cell lysates 
were harvested for Western blot analysis of JNK and c-Jun activation. Wei et al. Journal of Translational Medicine 2010, 8:37
http://www.translational-medicine.com/content/8/1/37
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mechanism by which NSC-741909 exerts its antitumor
cell activity.
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